Navigation Links
Antibody-coated stents: Indication of disadvantages
Date:11/14/2012

ogrel for one month. In contrast, the patients in the control groups were given clopidogrel for either 3 months (DES) or for six months (BMS).

The comparison with DES is mainly based on a single study

The comparative benefit assessment of DES- and antibody-stents is mainly based on a single study (TRIAS-HR). This was comparatively large - with 600 patients - and the risk of bias was low. Of the 304 patients who had been given an antibody-stent, 13 (4.3%) suffered a myocardial infarction, in comparison with 5 of 318 patients (1.6%) in the control group with DES.

The results for antibody-stents were also less favourable with respect to revascularization: re-operation was necessary for 71 of 297 (23.9%) patients in the antibody-stent group, in comparison with 51 of 315 patients (16.2%) in the DES group. As this conclusion was only based on a single study, IQWiG considers that there is no proof, but only an indication, of lesser benefit. This applies both to the outcome of myocardial infarction and to the outcome of revascularization.

An additional outcome criterion was a composite outcome including myocardial infarction and deaths due to other types of heart failure (cardiac mortality). Here too the results suggest that the antibody-stents are at a disadvantage. However, this is not an indication, but only a hint.

Mechanism of action of antibody-stents is questionable

The manufacturer of the antibody-stent claims that clopidogrel can be administered for a shorter period with their product. This may be of particular importance for patients undergoing surgery, as platelet inhibitors increase the risk of bleeding. Moreover, antibody-stents are supposed to be particularly effective in preventing restenoses in the vessels that are primarily affected.

Jrgen Windeler, the IQWiG Director, commented that, if this was the case, the rate of revascularization in these vessels would be lower. However
'/>"/>

Contact: Anna-Sabine Ernst
presse@iqwig.de
0049-221-356-850
Institute for Quality and Efficiency in Health Care
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Abiraterone: Indication of considerable added benefit in certain patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... The Pradaxa lawyers at Bernstein Liebhard ... convened for hundreds of Pradaxa bleeding lawsuits ... U.S. District Court, Southern District of Illinois. According ... 14th, the Conference addressed the status of depositions and ... Conference that Defendants submitted a list of early trial ...
(Date:5/19/2013)... 2013 Dr. Keith Chertok now provides gum ... unhealthy gums and increase the chance of a healthier smile. ... Attachment Procedure (LANAP) not only removes diseased gum tissue in ... jaw bone for dental implants. , LANAP uses ... It can also help stimulate the healthy tissue as well ...
(Date:5/19/2013)... Yeast infections are common in both men and women. ... human body. A new yeast infection treatment product has been ... method of application to help eliminate over growth of the ... men and women searching for a natural process of yeast ... food and is stored in the intestines. In small consumable ...
(Date:5/19/2013)... Malibu, CA (PRWEB) May 19, 2013 ... model addiction treatment center, has announced this week the ... completely through the brands’ social media channels. “We ... the addiction treatment community and to get feedback regarding ... Pax Prentiss, CEO and co-founder of the Passages ...
(Date:5/19/2013)... 2013 The AMTC team will be screening ... Georgia Convention & Trade Center on June 1st. Professionals and ... auditions are free of charge. , Actors, Models and Talent ... of successful artists and grads like Caitlin Kinney - SYTYCD, ... , Chris Young - on his Liquid Neon 2013 Tour, ...
Breaking Medicine News(10 mins):Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3Health News:Berkeley, CA Periodontist, Dr. Keith Chertok Now Treats Gum Disease Patients With Laser Gum Surgery Prior to Placing Dental Implants 2Health News:A Safe & Homeopathic Yeast Infection Relief by Yeastrol Now Available at HealthCareSupplementz.com with Massive Discount 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3Health News:Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent 2
... latest NHS news it is said that the breast cancer drug ... patients. But this is not happy news to the grieving family ... breast cancer. But NHS officials denied her the drug which led ... ,By profession she was an advertising art director from ...
... a plan to improve the bedside manners of would-be doctors. ... will be "embedded" with patients suffering from a chronic illness ... ,This program will be compulsory for the students and ... the US. "I think it would be ideal to have ...
... shaky from terror bombings and the 2004 tsunami, was ... parts of this Javanese cultural city, a prime tourist ... its cultural history, temples and vibrant arts and crafts ... overseas tourists. ,"We're suffering another setback," said ...
... claimed that ancient trees could provide clues to the pattern of ... Pingri, 75, from Guangdong Academy of Sciences has opined that rising ... but in fact was a part of the cyclical order of ... ancient trees, I discovered the temperature throughout history has risen and ...
... Initiated by their professor - high school and college students ... ,Isolation and characterisation of 30 macrophages has been made ... Genetics issue of June 9, 2006 has a report of ... the University of Pittsburgh. The report is about the characterization ...
... colleagues at the Indiana University Medical Center, Indianapolis say ... into having unwanted sex //. ,Unwanted sex ... researchers write in the June issue of the Archives ... result in risk for sexually transmitted infections and pregnancies. ...
Cached Medicine News:Health News:Indonesian Tourism on Downward Trend After Java Quake 2
(Date:5/17/2013)... N.Y. , May 17, 2013  Lakeland Industries, ... manufacturer of protective clothing for industry, healthcare and to ... will release its financial results for the fiscal 2013 ... Tuesday, May 21, 2013 at stock market close and ... at 4:30 p.m. eastern. (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ...
(Date:5/17/2013)... 17, 2013  Technology advances have had a ... with a constantly evolving communication environment, companies need ... communicating with internal executives. It is challenging, however, ... tactics and tools that are part of today,s ... study, Best Practices, LLC explores the various internal ...
(Date:5/17/2013)... 17, 2013  Sony Biotechnology Inc. ("Sony") today announced ... (SP6800).  Sony will be exhibiting and taking orders for ... at the San Diego Convention ... from May 20 - 22.  The ... commercial audio-visual technologies into new and novel functionalities for ...
Breaking Medicine Technology:Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2
... Oct. 26, 2011 Perrigo Company (Nasdaq: PRGO;TASE) ... a quarterly dividend of $0.08 per share, payable ... on November 25, 2011. Perrigo Company ... manufactures and distributes OTC and generic prescription (Rx) ...
... PARSIPPANY, N.J., Oct. 26, 2011 Pharmaceutical gurus know that ... industry is to get together with the field,s leading experts. ... overwhelmingly popular event that takes place just once a year: ... February 7-8 at the Hilton Parsippany Hotel in Parsippany, New ...
Cached Medicine Technology:Pharmaceutical Industry Leaders to Tackle Groundbreaking Challenges, Opportunities for Pharma & Biotech at Elite Event 2